Aespire Formulations Private Limited, a active private limited company, was established on 26 November 2013 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900DL2013PTC260979. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Asmira Healthcare Private Limited. It upholds a compliant status. Employing 5 professional, Its leadership includes Anupama Sarkar (Director), Rajat Sood (Director), Suman Sood (Director). Past directors included Rajat Sood. It holds ₹4.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 403, Fourth Floor Building No 49, 50 Red Rose, Nehru Place, New Delhi, Delhi, 110019.
U74900DL2013PTC260979
260979
26 November 2013
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Aespire Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama Sarkar | Director | 26 Nov 2013 | Current |
| Rajat Sood | Director | 26 May 2016 | Current |
| Suman Sood | Director | 26 Nov 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aespire Formulations Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial improvement in profitability, with a 204.32% increase in profit. The company's net worth Soared by an impressive increase of 17.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Aespire Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2017 | Hdfc Bank Limited | ₹4.50 M | Open |
Explore comprehensive loan charge details -
Aespire Formulations has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aespire Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aespire Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aespire Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Aespire Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 4.50 M registered on 30 May 2017 with Charge ID 100119133 was modified on 22 Feb 2021. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 4.50 M with Charge ID 100119133 was registered on 30 May 2017. was documented.
Progress on Rajat Sood was appointed as a Director was appointed as a Director on 26 May 2016 & has been associated with this company since 9 years 6 months . was documented.
The activity Anupama Sarkar was appointed as a Director was appointed as a Director on 26 Nov 2013 & has been associated with this company since 11 years 11 months . was completed.
The CIN of Aespire Formulations Private Limited is U74900DL2013PTC260979.
Aespire Formulations Private Limited is headquartered at 403, Fourth Floor Building No 49, 50 Red Rose, Nehru Place, New Delhi, Delhi, 110019.
Aespire Formulations Private Limited was incorporated on 26 November 2013.
The current directors of Aespire Formulations Private Limited are
The primary industry of Aespire Formulations Private Limited is Trade.
Aespire Formulations Private Limited is unlisted.
The authorized capital of Aespire Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aespire Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX